Kimia Farma Persero Tbk (KAEF) - Total Liabilities
Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has total liabilities worth Rp11.73 Trillion IDR (≈ $687.06 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Kimia Farma Persero Tbk to track the company's year-over-year net asset growth rate.
Kimia Farma Persero Tbk - Total Liabilities Trend (2002–2025)
This chart illustrates how Kimia Farma Persero Tbk's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Kimia Farma Persero Tbk generate to measure how efficiently the company converts operating cash flow to free cash.
Kimia Farma Persero Tbk Competitors by Total Liabilities
The table below lists competitors of Kimia Farma Persero Tbk ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Airtel Africa Plc
LSE:AAF
|
UK | GBX10.23 Billion |
|
Huangshan Tourism Development Co Ltd B
SHG:900942
|
China | $1.00 Billion |
|
Hope Education Group Co. Ltd
F:HE1
|
Germany | €12.42 Billion |
|
Barem Ambalaj Sanayi ve Ticaret a.s.
IS:BARMA
|
Turkey | TL5.71 Billion |
|
Selvas Ai Inc.
KQ:108860
|
Korea | ₩50.35 Billion |
|
Basso Industry Corp
TW:1527
|
Taiwan | NT$625.95 Million |
|
Samjin Pharm
KO:005500
|
Korea | ₩184.63 Billion |
|
Feintool International Holding
SW:FTON
|
Switzerland | CHF342.46 Million |
Liability Composition Analysis (2002–2025)
This chart breaks down Kimia Farma Persero Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kimia Farma Persero Tbk (KAEF) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kimia Farma Persero Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kimia Farma Persero Tbk (2002–2025)
The table below shows the annual total liabilities of Kimia Farma Persero Tbk from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Rp11.67 Trillion ≈ $684.01 Million |
+1.17% |
| 2024-12-31 | Rp11.54 Trillion ≈ $676.09 Million |
+3.09% |
| 2023-12-31 | Rp11.19 Trillion ≈ $655.84 Million |
+1.62% |
| 2022-12-31 | Rp11.01 Trillion ≈ $645.42 Million |
+4.62% |
| 2021-12-31 | Rp10.53 Trillion ≈ $616.92 Million |
+0.68% |
| 2020-12-31 | Rp10.46 Trillion ≈ $612.75 Million |
-4.41% |
| 2019-12-31 | Rp10.94 Trillion ≈ $641.04 Million |
+79.23% |
| 2018-12-31 | Rp6.10 Trillion ≈ $357.67 Million |
+73.23% |
| 2017-12-31 | Rp3.52 Trillion ≈ $206.47 Million |
+50.51% |
| 2016-12-31 | Rp2.34 Trillion ≈ $137.18 Million |
+70.37% |
| 2015-12-31 | Rp1.37 Trillion ≈ $80.52 Million |
+18.76% |
| 2014-12-31 | Rp1.16 Trillion ≈ $67.80 Million |
+36.51% |
| 2013-12-31 | Rp847.58 Billion ≈ $49.67 Million |
+33.52% |
| 2012-12-31 | Rp634.81 Billion ≈ $37.20 Million |
+17.18% |
| 2011-12-31 | Rp541.74 Billion ≈ $31.74 Million |
-0.28% |
| 2010-12-31 | Rp543.26 Billion ≈ $31.83 Million |
-4.24% |
| 2009-12-31 | Rp567.31 Billion ≈ $33.24 Million |
+13.94% |
| 2008-12-31 | Rp497.91 Billion ≈ $29.18 Million |
+4.01% |
| 2007-12-31 | Rp478.71 Billion ≈ $28.05 Million |
+22.57% |
| 2006-12-31 | Rp390.57 Billion ≈ $22.89 Million |
+17.15% |
| 2005-12-31 | Rp333.38 Billion ≈ $19.53 Million |
-7.10% |
| 2004-12-31 | Rp358.85 Billion ≈ $21.03 Million |
-41.39% |
| 2003-12-31 | Rp612.31 Billion ≈ $35.88 Million |
+69.50% |
| 2002-12-31 | Rp361.25 Billion ≈ $21.17 Million |
-- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, researches, develops, manufactures, and sells pharmaceutical products in Indonesia and internationally. It offers generic drugs, ethical products, over-the-counter products, herbs, and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical produc… Read more